{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:21:18Z","timestamp":1781421678807,"version":"3.54.1"},"publisher-location":"Berlin, Heidelberg","reference-count":113,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540225683","type":"print"},{"value":"9783540280828","type":"electronic"}],"license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005]]},"DOI":"10.1007\/3-540-28082-0_16","type":"book-chapter","created":{"date-parts":[[2005,10,10]],"date-time":"2005-10-10T23:06:17Z","timestamp":1128985577000},"page":"449-468","source":"Crossref","is-referenced-by-count":12,"title":["Challenge Studies in Anxiety Disorders"],"prefix":"10.1007","author":[{"given":"M.E.","family":"Keck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Str\u00f6hle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0006-3223(92)90138-P","volume":"32","author":"J.L. Abelson","year":"1992","unstructured":"Abelson JL, Glitz D, Cameron OG (1992) Endocrine, cardiovascular and behavioral responses to clonidine in patients with panic disorder. Biol Psychiatry 32:18\u201325","journal-title":"Biol Psychiatry"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0893-133X(00)00182-2","volume":"24","author":"J.L. Abelson","year":"2000","unstructured":"Abelson JL, Le M\u00e9lledo JM, Bichet DG (2000) Dose response of arginine vasopressin to the CCK-B agonist pentagastrin. Neuropsychopharmacology 24:161\u2013169","journal-title":"Neuropsychopharmacology"},{"key":"16_CR3","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1046\/j.1471-4159.1996.66041610.x","volume":"66","author":"J. Akiyoshi","year":"1996","unstructured":"Akiyoshi J, Moriyama T, Isogawa K, Miyamoto M, Sasaki I, Kuga K, Yamamoto H, Yamada K, Fugii I (1996) CCk-4-induced calcium mobilization in T cells is enhanced in panic disorder. J Neurochem 66:1610\u20131615","journal-title":"J Neurochem"},{"key":"16_CR4","first-page":"73","volume":"41","author":"C. Bass","year":"1989","unstructured":"Bass C, Gardner W (1989) Hyperventilation in clinical practice. Br J Hosp Med 41:73\u201381","journal-title":"Br J Hosp Med"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archpsyc.58.2.114","volume":"58","author":"M. Battaglia","year":"2001","unstructured":"Battaglia M, Bertella S, Ogliari A, Bellodi L, Smeraldi E (2001) Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder. Arch Gen Psychiatry 58:114\u2013119","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1176\/ajp.155.9.1184","volume":"155","author":"L. Bellodi","year":"1998","unstructured":"Bellodi L, Perna G, Caldirola D, Arancio C, Bertani A, Di Bella D (1998) CO2-induced panic attacks: a twin study. Am J Psychiatry 155:1184\u20131188","journal-title":"Am J Psychiatry"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1176\/ajp.152.8.1180","volume":"152","author":"C. Benkelfat","year":"1995","unstructured":"Benkelfat C, Bradwejn J, Meyer E (1995) Functional neuroanatomy of CCk-4-induced anxiety in normal healthy volunteers. Am J Psychiatry 152:1180\u20131184","journal-title":"Am J Psychiatry"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00004714-199704000-00006","volume":"17","author":"A. Bertani","year":"1997","unstructured":"Bertani A, Perna G, Caldirola D, Arancio C, Bellodi L (1997) Pharmacologic effect of paroxetine, sertraline and imipramine on reactivity to the 35% CO2 challenge: a double blind, random, placebo controlled study. J Clin Psychopharmacol 17:97\u2013101","journal-title":"J Clin Psychopharmacol"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1176\/ajp.155.9.1178","volume":"155","author":"A. Bisaga","year":"1998","unstructured":"Bisaga A, Katz JL, Antonini A, Wright CE, Margouleff C, Gorman JM, Eidelberg D (1998) Cerebral glucose metabolism in women with panic disorder. Am J Psychiatry 155:1178\u20131183","journal-title":"Am J Psychiatry"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0149-7634(01)00056-2","volume":"25","author":"C. Blanchard","year":"2001","unstructured":"Blanchard C, Hynd AL, Minke KA, Minemoto T, Blanchard RJ (2001) Human defensive behaviors to threat scenarios show parallels to fear-and anxiety-related defense patterns of non-human mammals. Neurosci Biobehav Rev 25:761\u2013770","journal-title":"Neurosci Biobehav Rev"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0034-5687(95)00045-F","volume":"101","author":"A.C. Bonham","year":"1995","unstructured":"Bonham AC (1995) Neurotransmitters in the CNS control of breathing. Respir Physiol 101:219\u2013230","journal-title":"Respir Physiol"},{"key":"16_CR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004850-199503000-00006","volume":"10","author":"W Boyer","year":"1995","unstructured":"Boyer W(1995) Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a metaanalysis. Int Clin Psychopharmacol 10:45\u201349","journal-title":"Int Clin Psychopharmacol"},{"key":"16_CR13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/ajp.151.2.261","volume":"151","author":"J. Bradwejn","year":"1994","unstructured":"Bradwejn J, Koszycki D (1994) Imipramine antagonism of the paniogenic effects of cholecystokinin tetrapeptide in panic disorder patients. Am J Psychiatry 151:261\u2013263","journal-title":"Am J Psychiatry"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/0006-3223(95)00081-X","volume":"38","author":"J. Bradwejn","year":"1995","unstructured":"Bradwejn J, Koszycki D, Paradis M, Reece P, Hinton J, Sedman A (1995) Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers. Biol Psychiatry 38:742\u2013746","journal-title":"Biol Psychiatry"},{"key":"16_CR15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1176\/ajp.150.7.1111","volume":"150","author":"F. Brambilla","year":"1993","unstructured":"Brambilla F, Bellodi L, Perna G, Garberi A, Panerai A, Sacerdote P (1993) T cell cholecystokinin concentrations in panic disorder. Am J Psychiatry 150:1111\u20131113","journal-title":"Am J Psychiatry"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1192\/bjp.163.2.201","volume":"163","author":"A.C. Briggs","year":"1993","unstructured":"Briggs AC, Stretch DD, Brandon S (1993) Subtyping of panic disorder by symptom profile. Br J Psychiatry 163:201\u2013209","journal-title":"Br J Psychiatry"},{"key":"16_CR17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1523\/JNEUROSCI.10-01-00176.1990","volume":"10","author":"P.D. Butler","year":"1990","unstructured":"Butler PD, Weiss JM, Stout JC, Nemeroff CB (1990) CRF produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 10:176\u2013183","journal-title":"J Neurosci"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00006842-200007000-00014","volume":"62","author":"O.G. Cameron","year":"2000","unstructured":"Cameron OG, Zubieta JK, Grunhaus L (2000) Effects of yohimbine on cerebral blood flow, symptoms, and physiological function in humans. Psychosom Med 62:549\u2013559","journal-title":"Psychosom Med"},{"key":"16_CR19","first-page":"323","volume":"45","author":"D.B. Carr","year":"1984","unstructured":"Carr DB, Sheehan DV (1984) Panic anxiety: a new biological model. J Clin Psychiatry 45:323\u2013330","journal-title":"J Clin Psychiatry"},{"key":"16_CR20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1472-8206.1995.tb00289.x","volume":"9","author":"F. Chaouloff","year":"1996","unstructured":"Chaouloff F (1996) Regulation of 5-HAT receptors by corticosteroids: where do we stand? Fundam Clin Pharmacol 9:219\u2013233","journal-title":"Fundam Clin Pharmacol"},{"key":"16_CR21","first-page":"901","volume-title":"Neuropsychopharmacology\u2013the fifth generation of progress","author":"D.S. Charney","year":"2002","unstructured":"Charney DS, Drevets WC (2002) Neurobiological basis of anxiety disorders. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds)Neuropsychopharmacology\u2013the fifth generation of progress. Lippincott Williams and Wilkins, Philadelphia, pp 901\u2013930"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archpsyc.1985.01790280040004","volume":"42","author":"D.S. Charney","year":"1986","unstructured":"Charney DS, Heninger GR (1986) Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of alprazolam treatment. Arch Gen Psychiatry 42:458\u2013467","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0447.1992.tb03266.x","volume":"86","author":"D.S. Charney","year":"1992","unstructured":"Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR (1992) Noradrenergicneuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatr Scand 86:273\u2013282","journal-title":"Acta Psychiatr Scand"},{"key":"16_CR24","first-page":"179","volume-title":"Advances in the neurobiology of panic disorder","author":"J.D. Coplan","year":"1996","unstructured":"Coplan JD, Klein DF (1996) Pharmacologic probes in panic disorder. In: Westenberg HGM, den Boer JA, Murphy DL (eds) Advances in the neurobiology of panic disorder. Wiley, New York, pp 179\u2013204"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1001\/archpsyc.55.2.130","volume":"55","author":"J.D. Coplan","year":"1998","unstructured":"Coplan JD, Goetz R, Klein DF (1998a) Plasma cortisol concentrations preceding lactateinduced panic. Psychological, biochemical, and physiological correlates. Arch Gen Psychiatry 55:130\u2013136","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/archpsyc.55.5.473","volume":"55","author":"J.D. Coplan","year":"1998","unstructured":"Coplan JD, Trost R, Owens MJ (1998b) Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions. Arch Gen Psychiatry 55:473\u2013477","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0006-3223(97)87457-4","volume":"41","author":"W. Coryell","year":"1997","unstructured":"Coryell W (1997) Hypersensitivity to carbon dioxide as a disease-specific trait marker. Biol Psychiatry 41:259\u2013263","journal-title":"Biol Psychiatry"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0149-7634(98)00011-6","volume":"22","author":"V. Daug\u00e9","year":"1998","unstructured":"Daug\u00e9 V, L\u00e9na I (1998) CCK in anxiety and cognitive processes. Neurosci Biobehav Rev 22:815\u2013825","journal-title":"Neurosci Biobehav Rev"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/syn.890060109","volume":"6","author":"V. Daug\u00e9","year":"1990","unstructured":"Daug\u00e9 V, Bohme GA, Crawley JN, Durieux C, Stutzmann JM (1990) Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264. Synapse 6:73\u201380","journal-title":"Synapse"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1037\/0735-7044.100.6.814","volume":"100","author":"M. Davis","year":"1986","unstructured":"Davis M (1986) Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm. Behav Neurosci 100:814\u2013824","journal-title":"Behav Neurosci"},{"key":"16_CR31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4088\/JCP.v61n0203","volume":"61","author":"N. De Martinidis","year":"2000","unstructured":"De Martinidis N, Rynn M, Rickels K (2000) Prior benzodiazepine use andbuspirone response in the treatment of generalized anxiety disorder. J Clin Psychiatry 61:91\u201394","journal-title":"J Clin Psychiatry"},{"key":"16_CR32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archpsyc.1989.01810060031006","volume":"46","author":"C. De Montigny","year":"1989","unstructured":"De Montigny C (1989) Cholecystokinin tetrapeptide induces panic like attacks in healthy volunteers. Arch Gen Psychiatry 46:511\u2013517","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/026988119601000106","volume":"10","author":"J.F.W. Deakin","year":"1996","unstructured":"Deakin JFW (1996) 5-HAT antidepressant drugs and the psychosocial origins of depression. J Psychopharmacol 10:31\u201338","journal-title":"J Psychopharmacol"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0140-6736(83)90076-4","volume":"2","author":"R. Dorow","year":"1983","unstructured":"Dorow R, Horowski R, Paschelke G, Amin M (1983) Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet 2:98\u201399","journal-title":"Lancet"},{"key":"16_CR35","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1523\/JNEUROSCI.17-05-01838.1997","volume":"17","author":"P.W. Frankland","year":"1997","unstructured":"Frankland PW, Josselyn SA, Bradwejn J, Vaccarino FJ, Yeomans JS (1997) Activation of amygdala cholecystokinin B receptors potentiates the acoustic startle response in the rat. J Neurosci 17:1838\u20131847","journal-title":"J Neurosci"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0006-3223(94)90091-4","volume":"36","author":"A.W. Goddard","year":"1994","unstructured":"Goddard AW, Sholomskas DE, Augeri FM (1994) Effects of tryptophan depletion in panic disorders. Biol Psychiatry 36:775\u2013777","journal-title":"Biol Psychiatry"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/archpsyc.1997.01830150097014","volume":"54","author":"R. Goldstein","year":"1997","unstructured":"Goldstein R, Wickramaratne P, Horwath E, Weissmann M (1997) Familial aggregation and phenomenology of \u201cearly\u201d-onset (at or before age 20 years) in panic disorder. Arch Gen Psychiatry 54:271\u2013278","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archpsyc.1988.01800250035006","volume":"45","author":"J.M. Gorman","year":"1988","unstructured":"Gorman JM, Fyer MR, Goetz R (1988) Ventilatory physiology of patientswith panic disorder. Arch Gen Psychiatry 45:31\u201339","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","volume":"157","author":"J.M. Gorman","year":"2000","unstructured":"Gorman JM, Kent JM, Sullivan GM, Coplan JD (2000) Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157:493\u2013505","journal-title":"Am J Psychiatry"},{"key":"16_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0166-4328(93)90097-A","volume":"58","author":"F.G. Graef","year":"1993","unstructured":"Graef FG, Silveira MC, Nogueira RL (1993) Role of the amygdala and periaqueductal gray in anxiety and panic. Behav Brain Res 58:123\u2013131","journal-title":"Behav Brain Res"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0278-5846(95)00305-3","volume":"20","author":"G. Griebel","year":"1996","unstructured":"Griebel G, Blanchard DC, Blanchard RJ (1996) Predator-elicited flight responses in Swiss-Webster mice: an experimental model of panic attacks. Prog Neuropsychopharmacol Biol Psychiatry 20:185\u2013205","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"16_CR42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0165-6147(93)90020-K","volume":"14","author":"J. Harro","year":"1993","unstructured":"Harro J, Vasar E, Bradwejn J (1993) Cholecystokinin in animal and human research of anxiety. Trends Pharmacol Sci 14:244\u2013249","journal-title":"Trends Pharmacol Sci"},{"key":"16_CR43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.1989.01810020037007","volume":"46","author":"E. Hollander","year":"1989","unstructured":"Hollander E, Liebowitz MR, Gorman JM, Cohen B, Fyer AJ, Klein DF (1989) Cortisol and sodium lactate-induced panic. Arch Gen Psychiatry 46:135\u2013140","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR44","first-page":"17","volume":"64","author":"F. Holsboer","year":"2003","unstructured":"Holsboer F (2003) The role of peptides in treatment of psychiatric disorders. J NeuralTransm 64:17\u201334","journal-title":"J NeuralTransm"},{"key":"16_CR45","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S0006-3223(98)00348-5","volume":"45","author":"M. Javanmard","year":"1999","unstructured":"Javanmard M, Shlik J, Kennedy SH, Vaccarino FJ, Houle S, Bradwejn J (1999) Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol Psychiatry 45:872\u2013882","journal-title":"Biol Psychiatry"},{"key":"16_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1677\/joe.0.1600169","volume":"160","author":"D.S. Jessop","year":"1999","unstructured":"Jessop DS (1999) Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. J Endocrinol 160:169\u2013180","journal-title":"J Endocrinol"},{"key":"16_CR47","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/0006-3223(91)90184-N","volume":"30","author":"R.S. Kahn","year":"1991","unstructured":"Kahn RS, Wetzler S (1991) m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 30:1139\u20131166","journal-title":"Biol Psychiatry"},{"key":"16_CR48","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0196-9781(01)00398-9","volume":"22","author":"M.E. Keck","year":"2001","unstructured":"Keck ME, Holsboer F (2001) Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 22:835\u2013844","journal-title":"Peptides"},{"key":"16_CR49","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/0024-3205(92)90543-X","volume":"50","author":"M. Kellner","year":"1992","unstructured":"Kellner M, Wiedemann K, Holsboer F (1992) ANF inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci 50:1835\u20131842","journal-title":"Life Sci"},{"key":"16_CR50","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1176\/ajp.152.9.1365","volume":"152","author":"M. Kellner","year":"1995","unstructured":"Kellner M, Herzog L, Yassouridis A, Holsboer F, Wiedemann K (1995) A possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactateinduced panic disorder. Am J Psychiatry 152:1365\u20131367","journal-title":"Am J Psychiatry"},{"key":"16_CR51","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/sj.mp.4000507","volume":"4","author":"J.L. Kennedy","year":"1999","unstructured":"Kennedy JL, Bradwein J, Koszycki D (1999) Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 4:284\u2013285","journal-title":"Mol Psychiatry"},{"key":"16_CR52","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archpsyc.1993.01820160076009","volume":"50","author":"D.F. Klein","year":"1993","unstructured":"Klein DF (1993) False suffocation alarms, spontaneous panics, and related conditions. Arch Gen Psychiatry 50:306\u2013317","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR53","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1176\/ajp.155.9.1147","volume":"155","author":"D.F. Klein","year":"1998","unstructured":"Klein DF (1998) Panic and phobic anxiety: phenotypes, endophenotypes, and genotypes. Am J Psychiatry 155:1147\u20131149","journal-title":"Am J Psychiatry"},{"key":"16_CR54","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1176\/ajp.151.8.1148","volume":"151","author":"H.W. Koenigsberg","year":"1994","unstructured":"Koenigsberg HW, Pollak CP, Fine J, Kakuma T (1994) Cardiac and respiratory activity in panicdisorder: effects of sleep and sleep lactate infusions. Am J Psychiatry 151:1148\u20131152","journal-title":"Am J Psychiatry"},{"key":"16_CR55","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/0006-3223(94)00190-E","volume":"37","author":"M.S. Kramer","year":"1995","unstructured":"Kramer MS, Cutler NR, Ballenger JC, Patterson WM, Mendels J (1995) A placebo-controlled trial of L-365,260, a CCK antagonist, in panic disorder. Biol Psychiatry 37:462\u2013466","journal-title":"Biol Psychiatry"},{"key":"16_CR56","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0006-3223(97)00536-2","volume":"44","author":"J.M. Le Mell\u00e9do","year":"1998","unstructured":"Le Mell\u00e9do JM, Bradwein J, Koszycki D, Bichet DG, Bellavance F (1998) The role of the \u03b2-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms. Biol Psychiatry 44:364\u2013366","journal-title":"Biol Psychiatry"},{"key":"16_CR57","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02244438","volume":"105","author":"K.P. Lesch","year":"1991","unstructured":"Lesch KP, Hoh A, Schulte HM (1991) Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive compulsive disorder. Psychopharmacology (Berl) 105:415\u2013420","journal-title":"Psychopharmacology"},{"key":"16_CR58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF02253597","volume":"106","author":"K.P. Lesch","year":"1992","unstructured":"Lesch KP, Wiesmann M, Hoh A (1992) 5-HT1A receptor-effector system responsivity in panic disorder. Psychopharmacology (Berl) 106:111\u2013117","journal-title":"Psychopharmacology"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0165-1781(87)90058-8","volume":"21","author":"A.P. Levin","year":"1987","unstructured":"Levin AP, Doran AR, Liebowitz MR, Fyer AJ, Klein DF, Paul SM (1987) Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatry Res 21:23\u201332","journal-title":"Psychiatry Res"},{"key":"16_CR60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.1995.tb04442.x","volume":"39","author":"C. Lines","year":"1995","unstructured":"Lines C, Challenor J, Traub M(1995) Cholecystokinin and anxiety in normal volunteers\u2014an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype-b-antagonist L-365,260. Br J Clin Pharmacol 39:235\u2013242","journal-title":"Br J Clin Pharmacol"},{"key":"16_CR61","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1126\/science.290.5489.131","volume":"290","author":"K. L\u00f6w","year":"2000","unstructured":"L\u00f6w K, Crestani F, Keist R, Benke D, Br\u00fcnig I (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131\u2013134","journal-title":"Science"},{"issue":"Suppl 6","key":"16_CR62","first-page":"5","volume":"57","author":"I. Lucki","year":"1996","unstructured":"Lucki I (1996) Serotonin receptor specificity in anxiety disorders. J Clin Psychiatry 57(Suppl 6):5\u201310","journal-title":"J Clin Psychiatry"},{"key":"16_CR63","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archpsyc.55.8.715","volume":"55","author":"A.L. Malizia","year":"1998","unstructured":"Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ (1998) Decreased brain GABAA-benzodiazepine receptor binding in panic disorder. Arch Gen Psychiatry 55:715\u2013720","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR64","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1037\/0033-2909.108.3.403","volume":"108","author":"R.J. Mc Nally","year":"1990","unstructured":"Mc Nally RJ (1990) Psychological approaches to panic disorder: a review. Psychol Bull 108:403\u2013419","journal-title":"Psychol Bull"},{"key":"16_CR65","first-page":"867","volume-title":"Neuropsychopharmacology\u2014the fifth generation of progress","author":"K.R. Merikangas","year":"2002","unstructured":"Merikangas KR (2002) Genetic and other vulnerability factors for anxiety and stress disorders. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology\u2014the fifth generation of progress. Lippincott Williams and Wilkins, Philadelphia, pp 867\u2013882"},{"key":"16_CR66","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0925-4927(00)00048-2","volume":"98","author":"J.H. Meyer","year":"2000","unstructured":"Meyer JH, Swinson R, Kennedy SH (2000) Increased left posterior parietal-temporal cortex activation after D-fenfluramine in women with panic disorder. Psychiatry Res 98:133\u2013143","journal-title":"Psychiatry Res"},{"key":"16_CR67","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1749-6632.1985.tb29915.x","volume":"448","author":"E. Mezey","year":"1985","unstructured":"Mezey E, Reisine TD, Skirboll L, Beinfeld M, Kiss JZ (1985) CCK in themedial parvocellular subdivision of the paraventricular nucleus: coexistence with CRH. Ann NY Acad Sci 448:152\u2013156","journal-title":"Ann NY Acad Sci"},{"key":"16_CR68","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1192\/bjp.176.2.182","volume":"176","author":"H.E. Miller","year":"2000","unstructured":"Miller HE, Deakin JF, Anderson IM (2000) Effect of acute tryptophan depletion on CO2-induced anxiety in patients with panic disorder and normal volunteers. Br J Psychiatry 176:182\u2013188","journal-title":"Br J Psychiatry"},{"key":"16_CR69","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0197-0186(91)90063-J","volume":"19","author":"M.C. Miquel","year":"1991","unstructured":"Miquel MC, Doucet E, Boni C (1991) Central serotonin 1A receptor: respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain. Neurochem Int 19:453\u2013465","journal-title":"Neurochem Int"},{"key":"16_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0304-3940(02)01176-X","volume":"335","author":"K. Miyasaka","year":"2002","unstructured":"Miyasaka K, Kobayashi S, Ohta M, Kanai S, Yoshida Y, Nagata A, Matsui T, Noda T, Takuguchi S, Takata Y, Kawanami T, Funakoshi A (2002) Anxiety-related behaviors in cholecystokinin-A,B, and AB receptor gene knockout mice in the plus-maze. Neurosci Lett 335:115\u2013118","journal-title":"Neurosci Lett"},{"key":"16_CR71","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0031-6997(25)00052-3","volume":"34","author":"A.R. Mueller","year":"1982","unstructured":"Mueller AR, Lundberg DBA, Breese GR, Jonason Y (1982) The neuropharmacology of respiration control. Pharmacol Rev 34:255\u2013279","journal-title":"Pharmacol Rev"},{"key":"16_CR72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1192\/bjp.160.2.165","volume":"160","author":"D.J. Nutt","year":"1992","unstructured":"Nutt DJ, Lawson CW (1992) Panic attacks: a neurochemical overview of models and mechanisms. Br J Psychiatry 160:165\u2013178","journal-title":"Br J Psychiatry"},{"key":"16_CR73","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archpsyc.1990.01810220033004","volume":"47","author":"D.J. Nutt","year":"1990","unstructured":"Nutt DJ, Glue P, Lawson CW, Wilson S (1990) Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 47:917\u2013925","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR74","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0306-4522(93)90263-F","volume":"54","author":"Z.Z. Pan","year":"1993","unstructured":"Pan ZZ, Wessendorf MW, Williams JT (1993) Modulation by serotonin of the neurons in rat nucleus raphe magnus in vitro. Neuroscience 54:421\u2013429","journal-title":"Neuroscience"},{"key":"16_CR75","first-page":"860","volume":"46","author":"A.C. Pande","year":"1999","unstructured":"Pande AC, Greiner M, Adams JB (1999) Placebo-controlled trial of the CCK-B antagonist, CI-988 in panic disorder. Mol Psychiatry 46:860\u2013862","journal-title":"Mol Psychiatry"},{"key":"16_CR76","doi-asserted-by":"publisher","first-page":"10734","DOI":"10.1073\/pnas.95.18.10734","volume":"95","author":"C.L. Parks","year":"1998","unstructured":"Parks CL, Robinson PS, Sibille E (1998) Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci USA 95:10734\u201310739","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR77","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0165-1781(94)90085-X","volume":"52","author":"G. Perna","year":"1994","unstructured":"Perna G, Battaglia M, Garberi A, Arancio C, Bellodi L (1994) Carbon dioxide\/oxygen challenge test in panic disorder. Psychiatry Res 52:159\u2013171","journal-title":"Psychiatry Res"},{"key":"16_CR78","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0165-1781(95)02723-A","volume":"57","author":"G. Perna","year":"1995","unstructured":"Perna G, Gabriele A, Caldirola D, Bellodi L (1995) Hypersensitivity to inhalation of carbon dioxide and panic attacks. Psychiatry Res 57:267\u2013273","journal-title":"Psychiatry Res"},{"key":"16_CR79","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00004714-199706000-00006","volume":"17","author":"G. Perna","year":"1997","unstructured":"Perna G, Bertani A, Gabriele A, Politi E, Bellodi L (1997) Modification of 35% carbon dioxide hypersensitivity across one week of treatment with clomipramine and fluvoxamine: a double-blind, randomised, placebo-controlled study. J Clin Psychopharmacol 17:173\u2013178","journal-title":"J Clin Psychopharmacol"},{"key":"16_CR80","first-page":"1311","volume-title":"Psychopharmacology\u2014the fourth generation of progress","author":"L.H. Price","year":"1995","unstructured":"Price LH, Goddard AW, Barr LC, Goodman WK (1995) In: Bloom, FE, Kupfer, DJ (eds) Psychopharmacology\u2014the fourth generation of progress. Raven Press, New York, pp 1311\u20131323"},{"key":"16_CR81","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s00213-002-1044-z","volume":"161","author":"D. Radu","year":"2002","unstructured":"Radu D, Ahlin A, Svanborg P, Lindefors N (2002) Anxiogenic effects of the CCKB agonist pentagastrin in humans and dose-dependent increase in plasma C-peptide levels. Psychopharmacology (Berl) 161:396\u2013403","journal-title":"Psychopharmacology"},{"key":"16_CR82","first-page":"147","volume":"71","author":"D.E. Redmond Jr","year":"1981","unstructured":"Redmond DE Jr (1981) Clonidine and the primate locus coeruleus: evidence suggesting anxiolytic and anti-withdrawal effects. Prog Clin Biol Res 71:147\u2013163","journal-title":"Prog Clin Biol Res"},{"key":"16_CR83","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1176\/ajp.143.4.469","volume":"143","author":"E.M. Reiman","year":"1986","unstructured":"Reiman EM, Raichle ME, Robins E, Butler FK, Herscovitch P, Fox P, Perlmutter P (1986) The applications of positron emission tomography to the study of panic disorder. Am J Psychiatry 143:469\u2013477","journal-title":"Am J Psychiatry"},{"key":"16_CR84","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0272-7358(91)90092-9","volume":"11","author":"S. Reiss","year":"1991","unstructured":"Reiss S (1991) Expectancy model of fear, anxiety and panic. Clin Psychol Rev 11:141\u2013153","journal-title":"Clin Psychol Rev"},{"key":"16_CR85","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.155.7.910","volume":"155","author":"E. Romeo","year":"1998","unstructured":"Romeo E, Str\u00f6hle A, Di Michele F, Holsboer F, Pasini A, Rupprecht R (1998) Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155:910\u2013913","journal-title":"Am J Psychiatry"},{"key":"16_CR86","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0166-2236(99)01399-5","volume":"22","author":"R. Rupprecht","year":"1999","unstructured":"Rupprecht R, Holsboer F (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22:410\u2013416","journal-title":"Trends Neurosci"},{"key":"16_CR87","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1192\/bjp.148.5.526","volume":"148","author":"P. Salkovskis","year":"1986","unstructured":"Salkovskis P, Jones D, Clark D (1986) Respiratory control in the treatment of panic attacks: replication and extension with concurrent measurement of behaviour and pCO2. Br J Psychiatry 148:526\u2013532","journal-title":"Br J Psychiatry"},{"key":"16_CR88","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1037\/0021-843X.106.3.355","volume":"106","author":"N. Schmidt","year":"1997","unstructured":"Schmidt N, Lerew D, Jackson R (1997) The role of anxiety sensitivity in the pathogenesis of panic: prospective evaluation of spontaneous panic attacks during acute stress. J Abnorm Psychol 106:355\u2013364","journal-title":"J Abnorm Psychol"},{"key":"16_CR89","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0165-1781(00)00117-7","volume":"93","author":"K. Schruers","year":"2000","unstructured":"Schruers K, Klaassen T, Pols H, Overbeek T, Deutz NE, Griez E (2000) Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients. Psychiatry Res 93:179\u2013187","journal-title":"Psychiatry Res"},{"key":"16_CR90","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-1781(02)00262-7","volume":"113","author":"K. Schruers","year":"2002","unstructured":"Schruers K, van Diest R, Overbeek T, Griez E (2002) Acute L-5-hydroxytryptophan administration inhibits carbon-dioxide-induced panic in panic disorder patients. Psychiatry Res 113:237\u2013243","journal-title":"Psychiatry Res"},{"key":"16_CR91","doi-asserted-by":"publisher","first-page":"10477","DOI":"10.1073\/pnas.93.19.10477","volume":"93","author":"D.W. Schulz","year":"1996","unstructured":"Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J (1996) CP-154,526: a potent and selective nonpeptide antagonist of CRF receptors. Proc Natl Acad Sci USA 93:10477\u201310482","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR92","first-page":"H2630","volume":"272","author":"F.E. Seier","year":"1997","unstructured":"Seier FE, Kellner M, Yassouridis A, Heese R, Strian F, Wiedemann K (1997) Autonomic reactivity and hormonal secretion in lactate-induced panic attacks. AmJ Physiol 272:H2630\u2013H2638","journal-title":"AmJ Physiol"},{"key":"16_CR93","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1176\/ajp.148.1.142-b","volume":"148","author":"M.K. Shear","year":"1991","unstructured":"Shear MK, Fyer AJ, Josephson S, Fitzpatrick M, Klein DF (1991) Vulnerability to sodium lactate in panic disorder patients given cognitive therapy. Am J Psychiatry 148:795\u2013797","journal-title":"Am J Psychiatry"},{"key":"16_CR94","first-page":"332","volume":"22","author":"J. Shlik","year":"1997","unstructured":"Shlik J, Aluoja A, Vasar V, Vasar E, Podar T, Bradwein J (1997) Effects of citalopram on behavioral, cardiovascular, and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. J Psychiatry Neurosci 22:332\u2013340","journal-title":"J Psychiatry Neurosci"},{"key":"16_CR95","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1176\/ajp.155.9.1152","volume":"155","author":"J.W. Smoller","year":"1998","unstructured":"Smoller JW, Tsuang MT (1998) Panic and phobic anxiety: defining phenotypes for genetic studies. Am J Psychiatry 155:1152\u20131162","journal-title":"Am J Psychiatry"},{"key":"16_CR96","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0006-3223(98)00328-X","volume":"45","author":"A. Str\u00f6hle","year":"1999","unstructured":"Str\u00f6hle A, Romeo E, Hermann B, Di Michele F, Holsboer F (1999) Concentrations of 3\u03b1-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry 45:274\u2013277","journal-title":"Biol Psychiatry"},{"key":"16_CR97","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0893-133X(99)00115-3","volume":"22","author":"A. Str\u00f6hle","year":"2000","unstructured":"Str\u00f6hle A, Holsboer F, Rupprecht R (2000) Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorders. Neuropsychopharmacology 22:251\u2013256","journal-title":"Neuropsychopharmacology"},{"key":"16_CR98","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/archpsyc.60.2.161","volume":"60","author":"A. Str\u00f6hle","year":"2003","unstructured":"Str\u00f6hle A, Romeo E, di Michele F, Pasini A, Hermann B (2003) Induced panic attacks shift \u03b3-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder. Arch Gen Psychiatry 60:161\u2013168","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR99","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0306-4530(92)90003-P","volume":"17","author":"S.D. Targum","year":"1992","unstructured":"Targum SD (1992) Cortisol response during different anxiogenic challenges in panic disorder patients. Psychoneuroendocrinology 17:453\u2013458","journal-title":"Psychoneuroendocrinology"},{"key":"16_CR100","first-page":"101","volume":"6","author":"T.W. Uhde","year":"1992","unstructured":"Uhde TW, Tancer ME, Rubinow DR (1992) Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone responses to clonidine, yohimbine, caffeine, glucose, GRF, and TRH in panic disorder patients vs. healthy volunteers. Neuropsychopharmacology 6:101\u2013118","journal-title":"Neuropsychopharmacology"},{"key":"16_CR101","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","volume":"95","author":"V. Uzunova","year":"1998","unstructured":"Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 95:3239\u20133244","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR102","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0022-3565(25)13053-X","volume":"253","author":"R.J. Valentino","year":"1990","unstructured":"Valentino RJ, Curtis AL, Parris DG, Wehby RG (1990) Antidepressant actions on brain noradrenergic neurons. J Pharmacol Exp Ther 253:833\u2013840","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR103","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.1993.tb49931.x","volume":"697","author":"R.J. Valentino","year":"1993","unstructured":"Valentino RJ, Foote SL, Page ME (1993) The locus coeruleus as a site for integrating CRF and noradrenergic mediation of stress response. Ann NY Acad Sci 697:173\u2013188","journal-title":"Ann NY Acad Sci"},{"key":"16_CR104","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0924-977X(95)00070-6","volume":"6","author":"I.M. van Vliet","year":"1996","unstructured":"van Vliet IM, Slaap BR, Westenberg HG, Den Boer JA (1996) Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder. Eur Neuropsychopharmacol 6:103\u2013110","journal-title":"Eur Neuropsychopharmacol"},{"key":"16_CR105","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0165-0327(96)00033-X","volume":"39","author":"D.J. Veltman","year":"1996","unstructured":"Veltman DJ, van Zijderveld GA, van Dyck R (1996) Epinephrine infusions in panic disorder: a double-blind placebo-controlled study. J Affect Disord 39:133\u2013140","journal-title":"J Affect Disord"},{"key":"16_CR106","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/BF00444706","volume":"98","author":"H.G.M. Westenberg","year":"1989","unstructured":"Westenberg HGM, Den Boer JA (1989) Serotonin function in panic disorder: effect of L-5-hydroxytryptophan in patients and controls. Psychopharmacology (Berl) 98:283\u2013285","journal-title":"Psychopharmacology"},{"key":"16_CR107","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0165-1781(96)02001-X","volume":"62","author":"S. Wetzler","year":"1996","unstructured":"Wetzler S, Asnis GM, DeLecuona JM (1996) Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine. Psychiatry Res 62:77\u201382","journal-title":"Psychiatry Res"},{"key":"16_CR108","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/archpsyc.58.4.371","volume":"58","author":"K. Wiedemann","year":"2001","unstructured":"Wiedemann K, Jahn H, Yassouridis A, Kellner M (2001) Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks. Arch Gen Psychiatry 58:371\u2013377","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR109","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/archpsyc.1986.01800090090013","volume":"43","author":"S.W. Woods","year":"1986","unstructured":"Woods SW, Charney DS, Lake J, Goodman WK, Redmond DE, Heninger DR (1986) Carbon dioxide sensitivity in panic anxiety: ventilatory and anxiogenic response to carbon dioxide in healthy subjects and panic and anxiety patients before and after alprazolam treatment. Arch Gen Psychiatry 43:900\u2013909","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archpsyc.1988.01800250051007","volume":"45","author":"S.W. Woods","year":"1988","unstructured":"Woods SW, Charney DS, Goodman WK, Heninger GR (1988a) Carbon dioxide-induced anxiety: behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects. Arch Gen Psychiatry 45:43\u201352","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR111","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0140-6736(88)90484-9","volume":"2","author":"S.W. Woods","year":"1988","unstructured":"Woods SW, Kosten K, Krystal JH (1988b) Yohimbine alters regional cerebral blood flow in panic disorder [letter]. Lancet 2:678","journal-title":"Lancet"},{"key":"16_CR112","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00005344-199210000-00015","volume":"20","author":"V.K. Yeragani","year":"1992","unstructured":"Yeragani VK, Berger R, Pohl R (1992) Effects of yohimbine on heart rate variability in panic disorder patients and normal controls: a study of power spectral analysis of heart rate. J Cardiovasc Pharmacol 20:609\u2013618","journal-title":"J Cardiovasc Pharmacol"},{"key":"16_CR113","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.npp.1300131","volume":"28","author":"P. Zwanzger","year":"2003","unstructured":"Zwanzger P, Eser D, Aicher S, Schule C, Baghai TC (2003) Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study. Neuropsychopharmacology 28:979\u2013984","journal-title":"Neuropsychopharmacology"}],"container-title":["Handbook of Experimental Pharmacology","Anxiety and Anxiolytic Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-28082-0_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:18:38Z","timestamp":1778246318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/3-540-28082-0_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"ISBN":["9783540225683","9783540280828"],"references-count":113,"URL":"https:\/\/doi.org\/10.1007\/3-540-28082-0_16","relation":{},"ISSN":["0171-2004"],"issn-type":[{"value":"0171-2004","type":"print"}],"subject":[],"published":{"date-parts":[[2005]]}}}